Murat Cokol

6.6k total citations · 1 hit paper
33 papers, 2.2k citations indexed

About

Murat Cokol is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Murat Cokol has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Computational Theory and Mathematics and 7 papers in Pharmacology. Recurrent topics in Murat Cokol's work include Computational Drug Discovery Methods (16 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Bioinformatics and Genomic Networks (5 papers). Murat Cokol is often cited by papers focused on Computational Drug Discovery Methods (16 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Bioinformatics and Genomic Networks (5 papers). Murat Cokol collaborates with scholars based in United States, Türkiye and Canada. Murat Cokol's co-authors include Burkhard Rost, Rajesh Nair, Kaan Yılancıoğlu, Selim Çetiner, Batu Erman, Bree B. Aldridge, Zohar Weinstein, Andreas Bender, Nurdan Kuru and Frederick P. Roth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Murat Cokol

32 papers receiving 2.2k citations

Hit Papers

Finding nuclear localization signals 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murat Cokol United States 22 1.3k 397 304 234 218 33 2.2k
Tiziano Gallo Cassarino United Kingdom 9 2.5k 1.9× 230 0.6× 398 1.3× 88 0.4× 342 1.6× 11 4.0k
Nicholas Furnham United Kingdom 26 1.8k 1.4× 348 0.9× 239 0.8× 168 0.7× 227 1.0× 55 2.5k
Andrew Binkowski United States 4 1.2k 0.9× 260 0.7× 180 0.6× 141 0.6× 174 0.8× 4 1.8k
K.P. Battaile United States 34 2.1k 1.6× 467 1.2× 527 1.7× 95 0.4× 739 3.4× 131 3.6k
Alan Bridge Switzerland 23 3.1k 2.4× 232 0.6× 458 1.5× 74 0.3× 297 1.4× 44 4.1k
M.W. Vetting United States 32 2.5k 1.9× 83 0.2× 302 1.0× 401 1.7× 393 1.8× 59 3.4k
Stefan Steinbacher Germany 31 2.8k 2.1× 138 0.3× 240 0.8× 44 0.2× 146 0.7× 56 3.5k
Teck Kwang Lim Singapore 28 1.2k 0.9× 180 0.5× 150 0.5× 57 0.2× 216 1.0× 78 2.5k
Daniel Lim United States 23 3.0k 2.3× 62 0.2× 467 1.5× 323 1.4× 303 1.4× 38 4.4k
K. Sekar India 28 2.0k 1.5× 170 0.4× 245 0.8× 48 0.2× 171 0.8× 181 2.7k

Countries citing papers authored by Murat Cokol

Since Specialization
Citations

This map shows the geographic impact of Murat Cokol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Cokol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Cokol more than expected).

Fields of papers citing papers by Murat Cokol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Cokol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Cokol. The network helps show where Murat Cokol may publish in the future.

Co-authorship network of co-authors of Murat Cokol

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Cokol. A scholar is included among the top collaborators of Murat Cokol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Cokol. Murat Cokol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cokol, Murat, Zohar Weinstein, Kevin Shi, et al.. (2025). Analyzing the large and complex SFARI autism cohort data using the Genotypes and Phenotypes in Families (GPF) platform. Genome Research. 35(10). 2352–2362.
2.
Geisinger, Edward, Murat Cokol, Delaney G. Fisher, et al.. (2020). Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope. Nature Communications. 11(1). 4522–4522. 60 indexed citations
3.
Kara, Göknur, et al.. (2020). Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy. Colloids and Surfaces B Biointerfaces. 196. 111340–111340. 19 indexed citations
4.
Katzir, Itay, Murat Cokol, Bree B. Aldridge, & Uri Alon. (2019). Prediction of ultra-high-order antibiotic combinations based on pairwise interactions. PLoS Computational Biology. 15(1). e1006774–e1006774. 50 indexed citations
5.
Cokol, Murat, et al.. (2019). Miniaturized Checkerboard Assays to Measure Antibiotic Interactions. Methods in molecular biology. 1939. 3–9. 10 indexed citations
6.
Weinstein, Zohar, Nurdan Kuru, Szilvia Kiriakov, et al.. (2018). Modeling the impact of drug interactions on therapeutic selectivity. Nature Communications. 9(1). 3452–3452. 17 indexed citations
7.
Cokol, Murat, Chen Li, & Sriram Chandrasekaran. (2018). Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment. PLoS Computational Biology. 14(12). e1006677–e1006677. 28 indexed citations
8.
Bakan, Feray, et al.. (2018). Diagonal Method to Measure Synergy Among Any Number of Drugs. Journal of Visualized Experiments. 30 indexed citations
9.
Bakan, Feray, et al.. (2017). Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery. Colloids and Surfaces B Biointerfaces. 158. 175–181. 32 indexed citations
10.
Chandrasekaran, Sriram, et al.. (2016). Chemogenomics and orthology‐based design of antibiotic combination therapies. Molecular Systems Biology. 12(5). 872–872. 91 indexed citations
11.
Busser, Benoît, Laetitia Vanwonterghem, Murat Cokol, et al.. (2016). Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. OncoTargets and Therapy. Volume 9. 6843–6855. 29 indexed citations
12.
Bulusu, Krishna C., Rajarshi Guha, Daniel J. Mason, et al.. (2015). Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives. Drug Discovery Today. 21(2). 225–238. 138 indexed citations
13.
Cokol, Murat, Zohar Weinstein, Kaan Yılancıoğlu, et al.. (2014). Large-Scale Identification and Analysis of Suppressive Drug Interactions. Chemistry & Biology. 21(4). 541–551. 23 indexed citations
14.
Yılancıoğlu, Kaan, et al.. (2014). Oxidative Stress Is a Mediator for Increased Lipid Accumulation in a Newly Isolated Dunaliella salina Strain. PLoS ONE. 9(3). e91957–e91957. 257 indexed citations
15.
Güvenek, Ayşegül, et al.. (2014). Strength of Selection Pressure Is an Important Parameter Contributing to the Complexity of Antibiotic Resistance Evolution. Molecular Biology and Evolution. 31(9). 2387–2401. 205 indexed citations
16.
Cokol, Murat. (2013). Drugs and their Interactions. Current Drug Discovery Technologies. 10(2). 106–113. 13 indexed citations
17.
Cokol, Murat, et al.. (2012). Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α. BMC Cancer. 12(1). 450–450. 22 indexed citations
18.
Cokol, Murat & Raul Rodriguez‐Esteban. (2008). Visualizing evolution and impact of biomedical fields. Journal of Biomedical Informatics. 41(6). 1050–1052. 11 indexed citations
19.
Cokol, Murat, et al.. (2005). Emergent behavior of growing knowledge about molecular interactions. Nature Biotechnology. 23(10). 1243–1247. 47 indexed citations
20.
Cokol, Murat, Rajesh Nair, & Burkhard Rost. (2000). Finding nuclear localization signals. EMBO Reports. 1(5). 411–415. 581 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026